Navigatie
Marktvooruitzichten Voorraadscreener Dividend kalender Evenementen kalender Waardering van aandelen Markten Nieuws
Probeer gratis

Achieve Life Sciences

NASDAQ ACHV
$5.07 -0.14 -2.76%
Today share price
Canada
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 13 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

126.99M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
128.17M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.22
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
25.05M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
23.06 %

Upcoming events Achieve Life Sciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Achieve Life Sciences

Stock analysis Achieve Life Sciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-4.65 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
-87.70 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-5.25 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-0.05 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-55.23 7.67

Price change Achieve Life Sciences per year

6.63$ 16.10$
Min Max

Summary analysis Achieve Life Sciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Achieve Life Sciences

Revenue and net income Achieve Life Sciences

All parameters

Stock news Achieve Life Sciences

All news
12 december 2023 в 17:00

Achieve Life Sciences shares drop as analysts see delayed launch of smoking-cessation treatment

23 mei 2023 в 13:15

Achieve Life Sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results

21 januari 2023 в 00:10

Achieve Life Sciences Stock Rises on Top Shareholder's Engagement Plans

21 januari 2023 в 00:10

Achieve Life Sciences Stock Rises on Top Shareholder's Engagement Plans

15 november 2022 в 18:45

Achieve Life Sciences Shares Rise 12% After Private Placement Prices

15 november 2022 в 18:45

Achieve Life Sciences Shares Rise 12% After Private Placement Prices

1 juni 2022 в 15:25

Achieve Life Sciences Gets $2.5M Grant for Cytisinicline Phase 2 Trial

1 juni 2022 в 15:20

Achieve Life Sciences Gets $2.5M Grant for Cytisinicline Phase 2 Trial

27 april 2022 в 15:26

Achieve Life Sciences Reports Positive Phase 3 Smoking-Cessation Study >ACHV

27 april 2022 в 15:20

Achieve Life Sciences Reports Positive Phase 3 Smoking-Cessation Study >ACHV

2 november 2021 в 15:45

Achieve Life Sciences to Launch Phase 2 Trial on E-Cigarette Cessation

2 november 2021 в 15:45

Achieve Life Sciences to Launch Phase 2 Trial on E-Cigarette Cessation

4 oktober 2021 в 14:15

Achieve Life Sciences started at buy with $25 stock price target at Alliance Global

29 juli 2020 в 15:12

Лидеры и аутсайдеры Уолл-cтрит: Sonoma Pharma, Boxlight, Achieve Life Sciences, Eastman Kodak

About company Achieve Life Sciences

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Address:
1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
Company name: Achieve Life Sciences
Issuer ticker: ACHV
ISIN: US0044685008
Country: Canada
Exchange: NASDAQ
Currency: $
IPO date: 1995-10-13
Sector: Healthcare
Industry: Biotechnology
Site: https://www.achievelifesciences.com

On which stock exchange are Achieve Life Sciences (ACHV) stocks traded?

Achieve Life Sciences (ACHV) stocks are traded on NASDAQ.

What is the ticker of Achieve Life Sciences stocks (ACHV)?

The stock ticker of Achieve Life Sciences’s stocks or in other words, the code is ACHV. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Achieve Life Sciences (ACHV) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Achieve Life Sciences (ACHV) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Achieve Life Sciences (ACHV) stocks traded?

Achieve Life Sciences (ACHV) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Achieve Life Sciences (ACHV) stocks today?

The current price of Achieve Life Sciences stocks on 17.05.2024 is 5.07 dollars. per share.

What is the dynamics of Achieve Life Sciences (ACHV) stocks from the beginning of the year?

Achieve Life Sciences (ACHV) quotes have increased by 21.58% from the beginning of the year up to 5.07 dollars. per 1 stocks.

How much did Achieve Life Sciences (ACHV) stocks increase in мае 2024?

This month Achieve Life Sciences (ACHV) quotes have increased by 12.17% to 5.07 dollars. per share.

How much are Achieve Life Sciences (ACHV) stocks worth?

Today, on October, 17.05.2024 Achieve Life Sciences’s (ACHV) stocks cost 5.07 dollars..

What is the market capitalization of Achieve Life Sciences (ACHV)?

Capitalization is the market value of Achieve Life Sciences (ACHV) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 17.05.2024, the market capitalization of Achieve Life Sciences (ACHV) is estimated at about 126994039 dollars.